INVOKANA or canagliflozin is an oral drug administered to patients with type 2 diabetes over the last four years to reduce blood sugar glucose levels. The drug works as a sodium-glucose cotransporter 2 inhibitor, increasing the release of sugar into the urine. Other brand names of the drug include Invokamet and Invokamet XR. Since its …